These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34924305)
1. Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myeloma. Giri S; Dahal S; Bal S; Godby KN; Richman J; Olszewski AJ; Williams GR; Brown C; Buford TW; Costa LJ; Bhatia S J Geriatr Oncol; 2022 May; 13(4):486-492. PubMed ID: 34924305 [TBL] [Abstract][Full Text] [Related]
2. Impact of Pre-Treatment NLR and Other Hematologic Biomarkers on the Outcomes of Early-Stage Non-Small-Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy. Aduquaye M; Dube S; Bashir B; Chowdhury A; Ahmed N; Leylek A; Kim J; Lambert P; Bucher O; Hunter W; Sivananthan G; Koul R; Rathod S Curr Oncol; 2022 Jan; 29(1):193-208. PubMed ID: 35049693 [TBL] [Abstract][Full Text] [Related]
3. Frailty and inflammatory markers in older adults with cancer. Nishijima TF; Deal AM; Williams GR; Guerard EJ; Nyrop KA; Muss HB Aging (Albany NY); 2017 Mar; 9(3):650-664. PubMed ID: 28273043 [TBL] [Abstract][Full Text] [Related]
4. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation. Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969 [TBL] [Abstract][Full Text] [Related]
5. Baseline neutrophil-lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy. van Hootegem SJM; Smithers BM; Gotley DC; Brosda S; Thomson IG; Thomas JM; Gartside M; Barbour AP Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31676907 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection. Azizi M; Peyton CC; Boulware DC; Chipollini J; Juwono T; Pow-Sang JM; Spiess PE Eur Urol Focus; 2019 Nov; 5(6):1085-1090. PubMed ID: 29937330 [TBL] [Abstract][Full Text] [Related]
7. Elevated neutrophil-lymphocyte ratio predicts mortality following elective endovascular aneurysm repair. King AH; Schmaier AH; Harth KC; Kumins NH; Wong VL; Zidar DA; Kashyap VS; Cho JS J Vasc Surg; 2020 Jul; 72(1):129-137. PubMed ID: 32037083 [TBL] [Abstract][Full Text] [Related]
8. Association Between Neutrophil-Lymphocyte Ratio and Frailty: The Chinese Longitudinal Healthy Longevity Survey. Xu W; Liang Y; Lin Z Front Med (Lausanne); 2021; 8():783077. PubMed ID: 35047530 [No Abstract] [Full Text] [Related]
9. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L; Cai K; Wang K; Luo Q J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240 [TBL] [Abstract][Full Text] [Related]
10. Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19. Tufa A; Gebremariam TH; Manyazewal T; Asrat Y; Getinet T; Hundie TG; Webb DL; Hellström PM; Genet S PLoS One; 2022; 17(10):e0275391. PubMed ID: 36201435 [TBL] [Abstract][Full Text] [Related]
11. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study. Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 33309337 [TBL] [Abstract][Full Text] [Related]
12. Inflammation markers are associated with frailty in elderly patients with coronary heart disease. Hou P; Xue HP; Mao XE; Li YN; Wu LF; Liu YB Aging (Albany NY); 2018 Oct; 10(10):2636-2645. PubMed ID: 30325739 [TBL] [Abstract][Full Text] [Related]
13. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Shi L; Qin X; Wang H; Xia Y; Li Y; Chen X; Shang L; Tai YT; Feng X; Acharya P; Acharya C; Xu Y; Deng S; Hao M; Zou D; Zhao Y; Ru K; Qiu L; An G Oncotarget; 2017 Mar; 8(12):18792-18801. PubMed ID: 27852046 [TBL] [Abstract][Full Text] [Related]
14. [Association of platelet/lymphocyte ratio and neutrophil/lymphocyte ratio with protein-energy wasting in maintenance hemodialysis patients]. Hu SS; Zhou CM; Li Q; Su FX; Chen S; Da JJ; Zha Y Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(8):587-592. PubMed ID: 30818927 [No Abstract] [Full Text] [Related]
15. [Value of Neutrophil/Lymphocyte Ratio and Monocyte/Lymphocyte Ratio in the Prognosis of Patients with Multiple Myeloma]. Yang WH; Sun YQ; Zhang QK; Wei XF; Li G Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):122-130. PubMed ID: 33554808 [TBL] [Abstract][Full Text] [Related]
16. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab. Capone M; Giannarelli D; Mallardo D; Madonna G; Festino L; Grimaldi AM; Vanella V; Simeone E; Paone M; Palmieri G; Cavalcanti E; Caracò C; Ascierto PA J Immunother Cancer; 2018 Jul; 6(1):74. PubMed ID: 30012216 [TBL] [Abstract][Full Text] [Related]
17. Frailty in Older Adults With Multiple Myeloma: A Study of US Veterans. Patel BG; Luo S; Wildes TM; Sanfilippo KM JCO Clin Cancer Inform; 2020 Feb; 4():117-127. PubMed ID: 32083955 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors. Higaki A; Okayama H; Homma Y; Sano T; Kitai T; Yonetsu T; Torii S; Kohsaka S; Kuroda S; Node K; Matsue Y; Matsumoto S Sci Rep; 2022 Aug; 12(1):13606. PubMed ID: 35948607 [TBL] [Abstract][Full Text] [Related]
19. Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers. Li M; Spakowicz D; Burkart J; Patel S; Husain M; He K; Bertino EM; Shields PG; Carbone DP; Verschraegen CF; Presley CJ; Otterson GA; Kendra K; Owen DH J Cancer Res Clin Oncol; 2019 Oct; 145(10):2541-2546. PubMed ID: 31367835 [TBL] [Abstract][Full Text] [Related]
20. [Significance of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Multiple Myeloma]. Sun JY; Mu N; Mu J; Zhang CG; Wang DM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1185-1189. PubMed ID: 31418377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]